Guca2a

Guca2a Full Name

guanylate cyclase activator 2A (guanylin)

Guca2a Introduction

GUCA2A, which encodes the peptide hormone guanylin, has emerged as an important molecular target in gastrointestinal biology because of its central role in maintaining intestinal homeostasis. Guanylin is initially synthesized as a larger precursor peptide and then processed into a biologically active 15-amino-acid peptide containing four conserved cysteine residues that stabilize its structure through intramolecular disulfide bonds. In healthy intestinal tissue, guanylin functions as an endogenous ligand for the transmembrane receptor guanylate cyclase-C (GC-C, also known as GUCY2C). Once activated, this signaling pathway regulates cyclic GMP production, electrolyte transport, epithelial barrier integrity, and intestinal fluid balance. Researchers studying intestinal disorders increasingly focus on the GUCA2A-GUCY2C signaling axis because disruptions in this pathway are closely associated with abnormal epithelial proliferation, impaired barrier function, and chronic intestinal inflammation. As interest grows in gut microenvironment regulation and mucosal signaling networks, GUCA2A is becoming highly relevant in both translational medicine and gastrointestinal drug discovery.

One reason GUCA2A has attracted substantial attention is its direct involvement in controlling epithelial renewal and protecting intestinal physiology under stress conditions. Guanylin and the structurally related peptide uroguanylin cooperatively activate GUCY2C signaling, helping coordinate cell proliferation, metabolic balance, ion transport, and mucosal defense mechanisms in the intestinal epithelium. Studies using single-cell transcriptomic analysis have shown that GUCA2A is highly and selectively expressed in specialized intestinal epithelial populations, particularly brush border-associated cells in the duodenum, suggesting a tightly regulated local signaling system. Researchers also propose that guanylin may participate in autocrine and paracrine signaling loops that continuously regulate CFTR channel activity and intestinal fluid secretion. These findings are particularly important for scientists investigating diarrhea-related disorders, epithelial dysfunction, inflammatory bowel diseases, and intestinal permeability abnormalities, where altered fluid transport and mucosal signaling are common pathological features. Because the GC-C signaling pathway directly influences epithelial regeneration and tissue stability, GUCA2A is increasingly viewed as a biologically meaningful target for understanding how the intestine maintains equilibrium under both physiological and pathological conditions.

The strongest disease association for GUCA2A has been observed in colorectal cancer, where consistent downregulation of guanylin expression has been reported across multiple independent studies. Loss of GUCA2A expression is now considered a characteristic molecular event during colorectal tumorigenesis, and several investigations suggest that silencing of the GUCA2A-GUCY2C signaling axis may contribute to uncontrolled proliferation, metabolic reprogramming, and disruption of intestinal barrier integrity. Computational biology analyses and molecular profiling studies further indicate that reduced GUCA2A expression may have diagnostic and prognostic value in colorectal cancer patients, particularly for early-stage disease detection and risk stratification. Because GUCY2C expression is often retained in tumor tissues even when guanylin levels decline, researchers are actively exploring therapeutic strategies aimed at restoring this signaling pathway. This has positioned GUCA2A as more than a simple intestinal peptide gene; it is increasingly recognized as a promising biomarker candidate and a potential therapeutic entry point for colorectal cancer research, especially in efforts focused on precision oncology, gastrointestinal biomarker discovery, and targeted modulation of epithelial signaling pathways.

Alternate Names for Guca2a

GUANYL; GUCA2; GUCA2A; STARA; Guanylate cyclase activating protein 1; Guanylate cyclase activator 2A; Guanylin 2 intestinal heat stable; Guanylin precursor; Pro-Guanylin; Pro-Guanylin (a.a. 13-25); guanylate cyclase activator 2A (guanylin); GN

• 1.Piroozkhah M, et al.; Guanylate cyclase-C Signaling Axis as a theragnostic target in colorectal cancer: a systematic review of literature. Front Oncol. 2023, 13:1277265.
  2.Xu H, et al.; Identification and Verification of Core Genes in Colorectal Cancer. Biomed Res Int. 2020, 2020:8082697.